India to Colombia: Paclitaxel Export Trade Route

The India to Colombia Paclitaxel corridor is one of India's established pharmaceutical export routes, with 73 shipments documented worth a combined $2.4M USD. The route is dominated by FRESENIUS KABI ONCOLOGY LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's paclitaxel manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $32.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 20.1%, placing it at rank #1 among India's top paclitaxel export destinations globally.

On the import side, key buyers of Indian paclitaxel in Colombia include FRESENIUS KABI COLOMBIA SAS, HB HUMAN BIOSCIENCE S.A.S , NEXT PHARMA SURCING SAS and 17 others. FRESENIUS KABI COLOMBIA SAS is the single largest importer with 21 shipments valued at $956.4K USD.

India's paclitaxel exports to Colombia are driven primarily by a handful of large-scale manufacturers. FRESENIUS KABI ONCOLOGY LIMITED with 21 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Colombia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, VENUS REMEDIES LIMITED, VENUS REMEDIES LIMITED — together account for 78% of total trade value on this route. The average shipment value of $32.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as paclitaxel injection usp 100mg/16.7ml ea and palit spal 100(paclitaxel protein boundparticles for injectable suspension 100mg)nos, suggesting that buyers in Colombia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FRESENIUS KABI COLOMBIA SAS is the largest importer with 21 shipments worth $956.4K USD — representing 41% of all paclitaxel imports from India on this route. A total of 20 buyers are active on this corridor.